Project Grant R21DA060331
Award Date
7/15/25
Completion Date
6/30/27
Dollars Obligated
$429K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Oregon, USA
Similar Awards
This Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $842,400 to Oregon Health & Science University (OHSU) to develop chemical biology tools for illuminating cannabinoid signaling pathways in opioid use disorder. The objective is to expand OHSU's cannabinoid chemical biology toolkit, particularly towards the atypical cannabinoid receptor GPR55, and apply these tools in ex vivo and in vivo...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,383,618.00 in funding to The Johns Hopkins University to conduct research on the microglia-mediated adverse effects of cannabis (specifically delta-9-tetrahydrocannabinol or THC) on the maturation of the prefrontal cortex and cognitive function during adolescence. The research aims to elucidate the molecular and cellular mechanisms by which THC...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $716,455 to the University of Washington to conduct research on the impact of oral THC consumption during adolescence on adult mouse brain development and behavior. The key objectives of this 5-year research project are to: 1) Determine how long-term adolescent use of THC-gelatin alone or in combination with CBD impacts cannabimimetic responses and natural...
This federal Project Grant award of $360,100.00 was provided by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), to George Washington University. The funding will support research on the "Socio-Structural Determinants of Cannabis and Derived Psychoactive Cannabis Product Use and Consequences Among Young Adults." The project aims to investigate the increasing use of cannabis and derived psychoactive cannabis products,...
The National Institute on Drug Abuse (NIDA) awarded a $137,619 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Washington. The grant, awarded on January 19, 2025, will support research to investigate the role of tetrahydrocannabinol (THC) in mediating pain signaling in the basolateral amygdala (BLA) brain region. The study aims to determine how THC, acting through cannabinoid 1 receptors (CB1R), alters glutamatergic neuronal activity in the BLA...
This Project Grant award of $220,340 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research at Washington State University to investigate the role of microglia, a type of immune cell in the brain, as a mechanism underlying the cognitive deficits associated with adolescent cannabis use. The study aims to determine if microglial activation is necessary for the impairments in cognitive flexibility observed in adulthood...
This Project Grant award of $169,580 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports a novel animal model study to investigate the effects of delta-9-tetrahydrocannabinol (THC) exposure during brain development in ferrets. The study aims to use RNA sequencing, electrophysiology, and in vivo electrophysiology techniques to examine changes in cannabinoid type-1 receptor (CB1R) expression and function, as well as ocular...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,742,971.00 to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC) Division to investigate the epigenetic regulation of HIV/SIV and cocaine-induced inflammasome activation in the brain and gut, and the potential of cannabinoids to modulate this process. The key objectives are to: 1) Investigate the...
This Project Grant award of $616,372 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to identify the role of transposable elements (TEs) in neuroinflammation and transcriptional/epigenetic dysfunction related to HIV-1 infection and cannabinoid use. The research will utilize single-cell/nuclei multiome data from a non-human primate model, post-mortem human brain tissues, and a human brain organoid model adapted...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $246,000.00 to The Trustees of Princeton University to investigate the brain mechanisms underlying the therapeutic potential of psilocybin. The research aims to: 1) examine the accelerated acquisition of motivated behavior and task performance after psilocybin administration, and 2) identify the cellular and brain-wide substrates driving...